Physician profile
Kimberly E Riano
NPI 1033133566
$7,562.09
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,320 · 2022: $318 · 2023: $4,726 · 2024: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,618 · Food and Beverage: $239 · Education: $67.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,618.09 |
| Food and Beverage | $238.54 |
| Education | $67.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $6,764.31 | 2021-2024 | Nexplanon |
| Astellas Pharma US INC | $96.61 | 2024 | Veozah |
| Lilly USA, LLC | $74.93 | 2021-2022 | |
| Abbvie INC. | $71.19 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $50.62 | 2021-2022 | |
| Dexcom, INC. | $49.08 | 2021-2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $46.33 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.24 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $42.21 | 2022-2023 | Pifeltro, Isentress, Dificid |
| Novo Nordisk INC | $41.93 | 2024 | Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.18 | 2023 | Trulance, Xifaxan |
| Currax Pharmaceuticals LLC | $34.89 | 2021-2022 | |
| Axsome Therapeutics, INC. | $29.92 | 2023 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $27.28 | 2022 | |
| Therapeuticsmd, INC. | $23.09 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gen-Probe, INC. | $20.98 | 2021 | |
| Viiv Healthcare Company | $19.19 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.91 | 2021 | |
| Avion Pharmaceuticals | $16.67 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.10 | 2022 | |
| Hologic Sales and Service, LLC | $14.69 | 2022 | |
| Agile Therapeutics, INC. | $13.54 | 2023 | Twirla |
| Genentech USA, INC. | $5.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Riano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.